Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

BreastCancerTreatment

Home » BreastCancerTreatment
ESMO 2023 | SKB264 (TROP2-ADC) Shows Promise in the Treatment of HR+/HER2- Metastatic Breast Cancer, Advancing in Multiple Cancer Types

ESMO 2023 | SKB264 (TROP2-ADC) Shows Promise in the Treatment of HR+/HER2- Metastatic Breast Cancer, Advancing in Multiple Cancer Types

Posted by By Lisa Cui 2023.12.07
TROP2 (Trophoblast Cell-Surface Antigen 2) is highly expressed in various solid tumors, making it a hot target in the field of oncology. The development of antibody-drug conjugates (ADCs) targeting this…
Read More
ESMO 2023 | Professor Ning Liao: The Extension of the T-DXd Anti-HER2 Landscape in DESTINY-PanTumor01

ESMO 2023 | Professor Ning Liao: The Extension of the T-DXd Anti-HER2 Landscape in DESTINY-PanTumor01

Posted by By Lisa Cui 2023.12.04
Editor's Note: Anti-HER2 therapy has traditionally been implemented based on HER2 expression detected through immunohistochemistry. In clinical practice, a small subset of patients with HER2-negative expression may have HER2 gene…
Read More
Recent Posts
  • Professor Dingwei Ye: Building an Authoritative Academic Platform in Uro-Oncology and Driving Continuous Progress in Urothelial Carcinoma Management |
  • Professor Hao Zeng’s Team Publishes in JAMA Oncology: Innovative First-Line Immunotherapy Approach for Advanced FH-Deficient Renal Cell Carcinoma
  • AI-Driven Imaging Breakthrough in CAR-T Therapy丨Professor Stephen Schuster on Predicting Efficacy
  • Polatuzumab Improves Survival in Relapsed/Refractory DLBCL丨Phase III POLARGO Study Highlights
  • Breakthrough Discovery of LymphoMAPs in Large B-cell Lymphoma丨Professor David Russler-Germain on CAR T Therapy
Recent Comments
    Archives
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Media Medic Publishing Company Limited(HK)
    赛美出版有限公司（香港）
    Scroll to Top